Advanced search
Publication Cover
Expert Review of Clinical Pharmacology Volume 12, 2019 - Issue 3
Submit an article Journal homepage
313
Views
13
CrossRef citations to date
0
Altmetric
Review

Daunorubicin and cytarabine for certain types of poor-prognosis acute myeloid leukemia: a systematic literature review

Juan Eduardo Megías-Vericata Servicio de Farmacia, Área del Medicamento, Hospital Universitari i Politècnic La Fe, Valencia, SpainORCID Iconhttps://orcid.org/0000-0002-0369-5341View further author information
ORCID Icon,
David Martínez-Cuadrónb Servicio de Hematología y Hemoterapia, Hospital Universitari i Politècnic La Fe, Valencia, Spain;c CIBERONC, Instituto Carlos III, Madrid, SpainView further author information
,
Miguel Ángel Sanzb Servicio de Hematología y Hemoterapia, Hospital Universitari i Politècnic La Fe, Valencia, Spain;c CIBERONC, Instituto Carlos III, Madrid, SpainView further author information
,
José Luis Povedaa Servicio de Farmacia, Área del Medicamento, Hospital Universitari i Politècnic La Fe, Valencia, SpainView further author information
&
Pau Montesinosb Servicio de Hematología y Hemoterapia, Hospital Universitari i Politècnic La Fe, Valencia, Spain;c CIBERONC, Instituto Carlos III, Madrid, SpainCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3275-5593View further author information
ORCID Icon
Pages 197-218 | Received 23 Oct 2018, Accepted 21 Jan 2019, Published online: 06 Feb 2019

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Juan Eduardo Megías-Vericat, David Martínez-Cuadrón, Antonio Solana-Altabella & Pau Montesinos. (2020) Precision medicine in acute myeloid leukemia: where are we now and what does the future hold?. Expert Review of Hematology 13:10, pages 1057-1065.
Read now

Articles from other publishers (12)

Adersikha Pradhan, Manodeep Chakraborty, Oonglim Lepcha, Ananya Bhattacharjee, Devid Chutia & Nihar Ranjan Bhuyan. (2023) Cardioprotective effects of Rhododendron arboreum leaf extract against Doxorubicin-induced cardiotoxicity in Wistar rats by modulating electrocardiographic and cardiac biomarkers. Clinical Phytoscience 9:1.
Crossref
Anoop Titus, Huzaifa Ahmad Cheema, Arman Shafiee, Niloofar Seighali, Abia Shahid, Karan B. Bhanushali, Ashish Kumar, Safi U. Khan, Sumanth Khadke, Paaladinesh Thavendiranathan, W. Gregory Hundley, Marielle Scherrer-Crosbie, Anju Nohria, Tomas G. Neilan, Sourbha S. Dani, Khurram Nasir & Sarju Ganatra. (2023) Statins for Attenuating Cardiotoxicity in Patients Receiving Anthracyclines: A Systematic Review and Meta-Analysis. Current Problems in Cardiology 48:10, pages 101885.
Crossref
Emma C. St. Martin, Tian Yi Zhang & Gabriel N. Mannis. (2023) The Goldilocks Dilemma in AML: Too Young and Fit, but Not Young and Fit Enough. Clinical Lymphoma Myeloma and Leukemia 23:6, pages 410-412.
Crossref
Cristian Sandoval, Yolanda Calle, Karina Godoy & Jorge Farías. (2023) An Updated Overview of the Role of CYP450 during Xenobiotic Metabolization in Regulating the Acute Myeloid Leukemia Microenvironment. International Journal of Molecular Sciences 24:7, pages 6031.
Crossref
Aesha F. S. H. Abdassalam, Nahide Gulsah Deniz, Cigdem Sayil, Evren Onay-Ucar, Elif Mertoglu & Nazli Arda. (2023) Novel vitamin K3 analogs containing 3-N-substituted aromatic and piperazine rings with selective in vitro anticancer activity against HeLa, U87 MG, and MCF-7 cells. Medicinal Chemistry Research 32:3, pages 475-484.
Crossref
Giulia Catitti, Simone De Fabritiis, Davide Brocco, Pasquale Simeone, Domenico De Bellis, Simone Vespa, Serena Veschi, Laura De Lellis, Nicola Tinari, Fabio Verginelli, Marco Marchisio, Alessandro Cama, Antonia Patruno & Paola Lanuti. (2022) Flow Cytometry Detection of Anthracycline-Treated Breast Cancer Cells: An Optimized Protocol. Current Issues in Molecular Biology 45:1, pages 164-174.
Crossref
Hui Feng, Yi Liu, Mengyao Zhang, Ruimin Liu, Jincheng Wang, Wenjuan Wang, Pengcheng He, Penghui Zhang & Fan Niu. (2022) De Novo design of a humanized antiCD33 antibody-oridonin conjugate for acute myeloid leukemia therapy. Biochemical and Biophysical Research Communications 629, pages 152-158.
Crossref
Jing-Ting Chiou, Chia-Hui Huang, Ti-Hsiao Wu, Liang-Jun Wang, Yuan-Chin Lee, Po-Wei Huang & Long-Sen Chang. (2022) CREB/Sp1-mediated MCL1 expression and NFκB-mediated ABCB1 expression modulate the cytotoxicity of daunorubicin in chronic myeloid leukemia cells. Toxicology and Applied Pharmacology 435, pages 115847.
Crossref
Agata Krzak, Olga Swiech, Maciej Majdecki, Piotr Garbacz, Paulina Gwardys & Renata Bilewicz. (2021) Adjusting the Structure of β-Cyclodextrin to Improve Complexation of Anthraquinone-Derived Drugs. Molecules 26:23, pages 7205.
Crossref
Xiaojun Xu, Yongbin Ye, Xiaobo Wang, Bo Lu, Ziwen Guo & Shunjie Wu. (2021) JMJD3-regulated expression of IL-6 is involved in the proliferation and chemosensitivity of acute myeloid leukemia cells. Biological Chemistry 402:7, pages 815-824.
Crossref
Itzen Aguiñiga-Sánchez, Frida Montserrat Meléndez-Ibarra, Edgar Ledesma-Martínez, Benny Weiss-Steider, Guadalupe Rosario Fajardo-Orduña, Rosalva Rangel-Corona, Sac-Nicte García-Gervasio, María Guadalupe Ramírez-Padilla, José Luis Lara-Castañeda & Edelmiro Santiago-Osorio. (2021) Improved Survival of Leukemic Mice Treated with Sodium Caseinate in Combination with Daunorubicin without Toxicity. Journal of Oncology 2021, pages 1-8.
Crossref
Florin Tripon, Mihaela Iancu, Adrian Trifa, George Andrei Crauciuc, Alina Boglis, Beata Balla, Adriana Cosma, Delia Dima, Marcela Candea, Erzsebet Lazar, Laura Jimbu & Claudia Banescu. (2020) Association Analysis of TP53 rs1042522, MDM2 rs2279744, rs3730485, MDM4 rs4245739 Variants and Acute Myeloid Leukemia Susceptibility, Risk Stratification Scores, and Clinical Features: An Exploratory Study. Journal of Clinical Medicine 9:6, pages 1672.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.